Barcelona, Spain · Founded 2005 · Privately Held (backing)
Developer of adenosine receptor modulators designed to advance treatments for orphan and neurological diseases. Palobiofarma is based in Barcelona, Spain and was founded in 2005. Its last known valuation is $79.3 million. It has raised $21.1 million.
Last price · $/share
—
Implied valuation
$79.3M
Total raised
$21.1M
Last round
—
Team — not yet on record
No current team members for Palobiofarma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Palobiofarma with a free account
·The complete investor list: 15 names
·Watch Palobiofarma: the Monday email on marks, rounds and moves
